• Title/Summary/Keyword: form release agent

Search Result 23, Processing Time 0.038 seconds

An experimental study on adhesion of concrete form release agent (콘크리트 거푸집 박리제의 부착력에 대한 실험적 연구)

  • Seo, Hyun-Jae;Park, Jong-Pil;Nam, Sun-Hwa;Gong, Min-Ho;Sng, Jae-Young;Oh, Sang-Keun
    • Proceedings of the Korean Institute of Building Construction Conference
    • /
    • 2018.11a
    • /
    • pp.77-78
    • /
    • 2018
  • Form-work is a must for construction work. In order to secure the best condition of the form surface and to increase the number of times, the form releasing agent is applied during the process of the form-work. The base oil of the form release agent which has been used already uses the oil which directly or indirectly affects the natural environment and the concrete. In this study, the basic study on the form release agent for concrete was carried out only for the effect of adhesion. The adhesive force of the tile is measured by the mortar to determine the change of the releasing agent and the adhesive strength.

  • PDF

Effect of the Various Curing Temperatures on the Finishability of Concrete using Aluminum Form (알루미늄 거푸집을 이용한 콘크리트의 양생온도변화에 따른 표면마감성에 관한 연구)

  • Lee, Dong-Gyu;Kim, Tae-Cheong;Baek, Dae-Hyun;Lee, Seong-Hoon;Han, Min-Cheol;Han, Cheon-Goo
    • Proceedings of the Korea Concrete Institute Conference
    • /
    • 2008.04a
    • /
    • pp.969-972
    • /
    • 2008
  • This study investigated the effect of the fundamental condition such as release agent, form conditions and types to the surface of concrete with aluminum form on the various temperatures. On the observation with the naked eyes, coated plywood and aluminum form without a scratch showed similar result, and the surface quality of the concrete with aluminum form was gradually decreased corresponding to the increase of the temperature.For the surface roughness, there is no remarkable tendency according to the temperature. However, the difference in accordance with release agent occurred.As void on the surface corresponding to the various temperature, the micro voids ranged $0.1{\sim}1mm$ were increased corresponding to the increasing temperature, so it was confirmed that the chemical reaction wae accelerated. And the voids of the other range also increased. the fundamental condition such as release agent, form conditions and types

  • PDF

A Study on the Surface Finish of Concrete Corresponding to Aluminum Form (알루미늄 거푸집을 이용한 모의구조체의 표면 마감성에 관한 연구)

  • Kim, Tae-Cheong;Lee, Dong-Gyu;Baek, Dae Hyun;Han, Min-Cheol;Han, Cheon-Goo
    • Proceedings of the Korean Institute of Building Construction Conference
    • /
    • 2008.05a
    • /
    • pp.47-50
    • /
    • 2008
  • This study analyzed the effect of increasing the number of times using aluminum form to the surface quality of concrete through small sized test, and the result was summarized as following. At the early stage, there was no remarkable change between aluminum and coated plywood form, and the surface quality of concrete both forms slightly declined corresponding with increasing the number of times using.As void on the surface corresponding to the number of times, the voids ranged 0.1~1mm were increased corresponding to increasing the number of times using forms, and the other range voids were also increased according to increasing the number of times using forms. It was confirmed that the surface of concrete was damaged gradually. For comparison with aluminum and coated plywood form though this experimental results, there might be no difference, if release agent was used properly.

  • PDF

Improved Dissolution of Poorly Water Soluble TD49, a Novel Algicidal Agent, via the Preparation of Solid Dispersion

  • Lee, Hyoung-Kyu;Cho, Hoon;Han, Hyo-Kyung
    • Journal of Pharmaceutical Investigation
    • /
    • v.40 no.3
    • /
    • pp.181-185
    • /
    • 2010
  • The objective of this study was to improve the extent of drug release as well as the dissolution rate of TD49, a novel algicidal agent, via the preparation of solid dispersion (SD). Among the various carriers tested, $Solutol^{(R)}$ HS15 was most effective to enhance the solubility of TD49. Subsequently, SDs of TD49 were prepared by using $Solutol^{(R)}$ HS15 and their solubility, dissolution characteristics and drug crystallinity were examined at various drug-carrier ratios. Solubili ty of TD49 was increased significantly in accordance with increasing the ratio of $Solutol^{(R)}$ HS15 in SDs. Compared to untreated powders and physical mixtures (PMs), SDs facilitated the faster and greater extent of drug release in water. Particularly, SD having the drug-carrier ratio of 1:20 exhibited approximately 90% of drug release within 1 hr. Differential scanning calorimetry (DSC) thermograms and X-ray diffraction (XRD) patterns suggested that SDs might enhance the dissolution of TD49 by changing the drug crystallinity to an amorphous form in addition to the increased solubilization of drug in the presence of $Solutol^{(R)}$ HS15. In conclusion, SD using $Solutol^{(R)}$ HS15 appeared to be effective to improve the extent of drug release and the dissolution rate of poorly water soluble TD49.

Characteristics of ethylcellulose microcapsules of sulfisoxazole

  • Oh, Doo-Man;Lee, Min-Hwa
    • Archives of Pharmacal Research
    • /
    • v.5 no.2
    • /
    • pp.61-70
    • /
    • 1982
  • Sulfisoxazole, a chemotherapeutic agent, was microencapsulated with ethylcellulose by means of phase separation form cyclohexane by temperatture change. The size distribution was determined by use of standard sieves and the effect of core to wall ratio was noted. To examine their shapes and usrface characteristics, the microcapsules were observed with a scanning electron microscope. Release of the drug from microcapsules into pH 7.5 buffer medium was studied. The release pattern was found to have similar properties to the release of a drug from an insoluble porous matrix reported. The apparent diffusion coefficient of sulfisoxazole was measured for the transport of the drug from the core of microcapsules into the surronding sink condition. The apparent diffusion coefficient increased with increasing capsule size.

  • PDF

Evaluation of Sustained-release Dosage Form with Novel Metformin Salts (새로운 메트포르민 산부가염을 이용한 서방성 제형 평가)

  • Kim, Dong-Wook
    • Journal of the Korea Academia-Industrial cooperation Society
    • /
    • v.16 no.11
    • /
    • pp.7838-7843
    • /
    • 2015
  • In this study, metformin hydrochloride for first choice of type 2 diabetes patient is administered relatively high dose, 1000 to 2000 mg orally once a day, and had very high water solubility, so it make difficult to swallow tablet to requires high amount of sustained release agent. To overcome these challenges, we used novel metformin salts had relatively low water solubility to minimize sustaining excipient for small size of dosage form. six novel metformin salts were synthesized by making metformin free form under reaction with NaOH and adding acid salts. we confirmed metformin stearate had the lowest water solubility and showed half drug release in dissolution study at 12hour. In conclusion, novel metformin salts had low water solubility can be used to reduce the size of sustained metformin tablet for improving patient compliance.

Inhibitory Action of Minocycline on Lipopolysaccharide-Induced Release of Nitric Oxide and Prostaglandin E2 in BV2 Microglial Cells

  • Kim, Sung-Soo;Kong, Pil-Jae;Kim, Bong-Seong;Sheen, Dong-Hyuk;Nam, Su-Youn;Chun, Wan-Joo
    • Archives of Pharmacal Research
    • /
    • v.27 no.3
    • /
    • pp.314-318
    • /
    • 2004
  • Microglia are the major inflammatory cells in the central nervous system and become activated in response to brain injuries such as ischemia, trauma, and neurodegenerative diseases including Alzheimer's disease (AD). Moreover, activated microglia are known to release a variety of proinflammatory cytokines and oxidants such as nitric oxide (NO). Minocycline is a semi-synthetic second-generation tetracycline that exerts anti-inflammatory effects that are completely distinct form its antimicrobial action. In this study, the inhibitory effects of minocycline on NO and prostaglandin E$_2$ (PGE$_2$) release was examined in lipopolysaccharides (LPS)-challenged BV2 murine microglial cells. Further, effects of minocycline on inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression levels were also determined. The results showed that minocycline significantly inhibited NO and PGE$_2$ production and iNOS and COX-2 expression in BV2 microglial cells. These findings suggest that minocycline should be evaluated as potential therapeutic agent for various pathological conditions due to the excessive activation of microglia.

Water-insoluble, Whey Protein-based Microcapsules for Controlled Core Release Application

  • Lee, Sung-Je
    • Journal of Dairy Science and Biotechnology
    • /
    • v.23 no.2
    • /
    • pp.115-123
    • /
    • 2005
  • Microcapsules consisting of natural, biodegradable polymers for controlled and/or sustained core release applications are needed. Physicochemical properties of whey proteins suggest that they may be suitable wall materials in developing such microcapsules. The objectives of the research were to develop water-insoluble, whey protein-based microcapsules containing a model water-soluble drug using a chemical cross-linking agent, glutaraldehyde, and to investigate core release from these capsules at simulated physiological conditions. A model water soluble drug, theophylline, was suspended in whey protein isolate (WPI) solution. The suspension was dispersed in a mixture of dichloromethane and hexane containing 1% biomedical polyurethane. Protein matrices were cross-linked with 7.5-30 ml of glutaraldehyde-saturated toluene (GAST) for 1-3 hr. Microcapsules were harvested, washed, dried and analyzed for core retention, microstructure, and core release in enzyme-free simulated gastric fluid (SGF) and simulated intestinal fluid(SIF) at $37^{\circ}C$. A method consisting of double emulsification and heat gelation was also developed to prepare water-insoluble, whey protein-based microcapsules containing anhydrous milkfat (AMF) as a model apolar core. AMF was emulsified into WPI solution (15${\sim}$30%, pH 4.5-7.2) at a proportion of 25${\sim}$50%(w/w, on dry basis). The oil-in-water emulsion was then added and dispersed into corn oil ($50^{\circ}C$) to form an O/W/O double emulsion and then heated at $85^{\circ}C$ for 20 min for gelation of whey protein wall matrix. Effects of emulsion composition and pH on core retention, microstructure, and water-solubility of microcapsules were determined. Overall results suggest that whey proteins can be used in developing microcapsules for controlled and sustained core release applications.

  • PDF

Formulation of Sustained-release Tablets of Felodipine using Hydrophilic Polymers and Non-ionic Surfactants (친수성고분자 및 비이온성 계면활성제를 이용한 펠로디핀 서방정제의 설계)

  • Lee, Jin-Kyo;Yang, Sung-Woon;Lee, Bong-Sang;Jeon, Hong-Ryeol;Lee, Jae-Hwi;Choi, Young-Wook
    • Journal of Pharmaceutical Investigation
    • /
    • v.36 no.4
    • /
    • pp.271-276
    • /
    • 2006
  • Felodipine, a calcium-antagonist of dihydropyridine type, is a poorly water soluble drug and has very low bioavailability. As preceding studies, use of solid dispersion systems and surfactants(solubilizers) has been suggested to increase dissolution and to improve bioavailability of felodipine. But in case of solid dispersion systems, large amount of toxic organic solvents should be used and manufacturing process time become longer than conventional process. In case of using surfactants, as time elapsed, decreasing of dissolution rate of felodipine due to crystallization has been reported. In this study, Copovidon as a hydrophilic polymer and $Transcutol^{\circledR}$ as a surfactant were combined to formulations if order to increase dissolution of felodipine and conventional wet granulation process were applied to manufacturing of formulations. The effect of Copovidon and $Transcutol^{\circledR}$ on the dissolution oi felodipine was investigated in-vitro. When Copovidon and $Transcutol^{\circledR}$ used simultaneously, the dissolution rate of felodipine was prominently increased compared with when used separately and the maximum increase in the dissolution of felodipine was 5.8 fold compared to control. This is most probably due to synergy effect by combination of Copovidon and $Transcutol^{\circledR}$. Felodipine sustained release tablets were successfully formulated using several grades of HPMC as a release retarding agent. The stability of felodipine sustained release tablet was evaluated after storage at accelerated condition($40^{\circ}C/75%\;RH$) for 6months in HDPE(High density polyethylene) bottle. Neither significant degradation nor change of dissolution rate for felodipine was observed after 6months. In conclusion, felodipine sustained release tablet was successfully formulated and dissolution of felodipine, poorly water soluble drug, was prominently increased and also stability was guaranteed by using combination system of hydrophilic polymer and surfactant.

Induction of Apoptosis by (-)-epigallocatechin-3-gallate in HL-60 Cells (인체 혈액암세포주(HL-60)에서 (-)-epigallocatechin-3-gallate에 의한 Aapoptosis 유도)

  • 이해미;김연정;박태선
    • Journal of Nutrition and Health
    • /
    • v.36 no.4
    • /
    • pp.382-388
    • /
    • 2003
  • (-)-Epigallocatechin-3-gallate (EGCG) is a polyphenolic compound found in peen tea leaves, and has been known to be one of the most potent catechin species which inhibits cell growth most possibly through an apoptotic cell death. We investigated the apoptotic activity of (-)-EGCG on the human myeloid leukemia cell line, HL-60. Our results of MTT test indicated that (-)-EGCG had a significant antiproliferation effect in HL-60 cells with $IC_{50}$/ (50% inhibition concentration) value of 65 $\mu$M. Giemsa statining of HL-60 cells treated with (-)-EGCG (100 $\mu$M) for 6hrs showed a typical apoptosis-specific morphological change including shrinkage of the cytoplasm, membrane blobbing and compaction of the nuclear chromatin. The DNA fragmentation was observed from the agarose gel electrophoresis of cells treated with (-)-EGCG for 3hrs or longer, and was progressed to a greater degree as treatment time increases. Treatment of the cells with (-)-EGCG (100 $\mu$M) resulted in a rapid release of mitochondrial cytochrome c into the cytosol, and a subsequent cleavage of caspase-3 to an active form in a treatment-time dependent manner. (-)-EGCG (100 $\mu$M) also stimulated proteolytic cleavage of poly-(ADP-ribose) polymerase (PARP) to an active form in HL-60 cells. Tlken together, (-)-EGCG appears to induce the apoptosis in human myeloid leukemia cells via a caspase-dependent pathway. These results suggest the possible application of (-)-EGCG, the major active compound in green tea, as an antiproliferative agent for cancer prevention.